Major Adverse Events in Patients with Peripheral Artery Disease after Endovascular Revascularization: A Retrospective Study

被引:7
|
作者
Kim, Mihui [1 ]
Yang, Yong Sook [1 ]
Ko, Young-Guk [2 ]
Choi, Mona [3 ]
机构
[1] Yonsei Univ, Coll Nursing, Brain Korea 21 4 Project, Seoul 03722, South Korea
[2] Yonsei Univ, Severance Cardiovasc Hosp, Div Cardiol, Coll Med, Seoul 03722, South Korea
[3] Yonsei Univ, Mo Im Kim Nursing Res Inst, Coll Nursing, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
diabetes mellitus; exercise; major adverse cardiovascular event; major adverse limb event; peripheral artery disease; CHRONIC KIDNEY-DISEASE; PHYSICAL-ACTIVITY; RISK-FACTORS; ASSOCIATION; EPIDEMIOLOGY; MECHANISMS; EXERCISE; SYSTEM;
D O I
10.3390/jcm11092547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: For peripheral artery disease (PAD) patients, after endovascular revascularization, it is crucial to manage associated factors that can affect the risk of major adverse events. We aimed to investigate the associated factors of major adverse events in these patients. Materials and Methods: We conducted a retrospective longitudinal analysis using the electronic medical records from a tertiary hospital in Korea and included the data of 1263 patients. Eligible patients were categorized into four groups based on diabetes mellitus (DM) and regular exercise. The major adverse events included major adverse limb events and major adverse cardiovascular events. Major adverse events-free survival was assessed using the Kaplan-Meier method, and associated factors of major adverse events were analyzed using Cox proportional hazards analyses. Results: Kaplan-Meier survival curves showed that patients with DM and non-regular exercise had a shorter major adverse events-free survival. The Cox regression analysis showed that for patients with critical limb ischemia or chronic kidney disease, the risk of major adverse events increased, while group variables were not significant. Conclusion: Target management of patients with DM, critical limb ischemia, and chronic kidney disease is essential to reduce major adverse events after endovascular revascularization in patients with PAD.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Time to Wound Healing and Major Adverse Limb Events in Patients with Critical Limb Ischemia Treated with Endovascular Revascularization
    Reed, Grant W.
    Salehi, Negar
    Giglou, Pejman R.
    Kafa, Rami
    Malik, Umair
    Maier, Michael
    Shishehbor, Mehdi H.
    ANNALS OF VASCULAR SURGERY, 2016, 36 : 190 - 198
  • [22] High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events
    Thomas, Peter E.
    Vedel-Krogh, Signe
    Kamstrup, Pia R.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (06) : 511 - 519
  • [23] The Association between Major Adverse Cardiovascular Events and Peripheral Artery Disease Burden
    Niiranen, Oskari
    Virtanen, Juha
    Rantasalo, Ville
    Ibrahim, Amer
    Venermo, Maarit
    Hakovirta, Harri
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2024, 11 (06)
  • [24] Principal predictors of major adverse limb events in diabetic peripheral artery disease: A narrative review
    Biscetti, Federico
    Cecchini, Andrea Leonardo
    Rando, Maria Margherita
    Nardella, Elisabetta
    Gasbarrini, Antonio
    Massetti, Massimo
    Flex, Andrea
    ATHEROSCLEROSIS PLUS, 2021, 46 : 1 - 14
  • [25] Vorapaxar for Prevention of Major Adverse Cardiovascular and Limb Events in Peripheral Artery Disease
    Morrison, Justin T.
    Govsyeyev, Nicholas
    Hess, Connie N.
    Bonaca, Marc P.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2022, 27
  • [26] Cost Analysis of Initial Treatment With Endovascular Revascularization, Open Surgery, or Primary Major Amputation in Patients With Peripheral Artery Disease
    Tang, Linda
    Paravastu, Sharath C. V.
    Thomas, Shannon D.
    Tan, Elaine
    Farmer, Eric
    Varcoe, Ramon L.
    JOURNAL OF ENDOVASCULAR THERAPY, 2018, 25 (04) : 504 - 511
  • [27] Prediction of Major Adverse Cardiovascular Events in Patients with Peripheral Artery Disease Using Circulating Immunomodulatory Proteins
    Li, Ben
    Shaikh, Farah
    Younes, Houssam
    Abuhalimeh, Batool
    Chin, Jason
    Rasheed, Khurram
    Zamzam, Abdelrahman
    Abdin, Rawand
    Qadura, Mohammad
    BIOMEDICINES, 2024, 12 (12)
  • [28] Revascularization Strategies for Patients With Femoropopliteal Peripheral Artery Disease
    Farhan, Serdar
    Enzmann, Florian K.
    Bjorkman, Patrick
    Kamran, Haroon
    Zhang, Zhongjie
    Sartori, Samantha
    Vogel, Birgit
    Tarricone, Arthur
    Linni, Klaus
    Venermo, Maarit
    van der Veen, Daphne
    Moussalli, Herve
    Mehran, Roxana
    Reijnen, Michel M. P. J.
    Bosiers, Marc
    Krishnan, Prakash
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (04) : 358 - 370
  • [29] Predictors of Underutilization of Medical Therapy in Patients Undergoing Endovascular Revascularization for Peripheral Artery Disease
    Altin, S. Elissa
    Castro-Dominguez, Yulanka S.
    Kennedy, Kevin F.
    Orion, Kristine C.
    Lanksy, Alexandra J.
    Abbott, J. Dawn
    Aronow, Herbert D.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (24) : 2911 - 2918
  • [30] EPIDEMIOLOGICAL CHARACTERISTICS OF PERIPHERAL ARTERY DISEASE: RETROSPECTIVE STUDY
    Popa, Setalia
    Baroi, Genoveva
    Popa, R. F.
    Datcu, D. M.
    Aursulesei, Viviana
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2013, 117 (01): : 95 - 100